|
1
|
Ferrin G, Aguilar-Melero P,
Rodríguez-Perálvarez M, Montero-Álvarez JL and de la Mata M:
Biomarkers for hepatocellular carcinoma: Diagnostic and therapeutic
utility. Hepat Med. 7:1–10. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Llovet JM, Di Bisceglie AM, Bruix J,
Kramer BS, Lencioni R, Zhu AX, Sherman M, Schwartz M, Lotze M,
Talwalkar J, et al: Design and endpoints of clinical trials in
hepatocellular carcinoma. J Natl Cancer Inst. 100:698–711. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hong YP, Li ZD, Prasoon P and Zhang Q:
Immunotherapy for hepatocellular carcinoma: From basic research to
clinical use. World J Hepatol. 7:980–992. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gerolami R, Uch R, Jordier F, Chapel S,
Bagnis C, Bréchot C and Mannoni P: Gene transfer to hepatocellular
carcinoma: Transduction efficacy and transgene expression kinetics
by using retroviral and lentiviral vectors. Cancer Gene Ther.
7:1286–1292. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pez F, Lopez A, Kim M, Chapel S, Bagnis C,
Bréchot C and Mannoni P: Wnt signaling and hepatocarcinogenesis:
Molecular targets for the development of innovative anticancer
drugs. J Hepatol. 59:1107–1117. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bhatia D, Thoppil RJ, Mandal A, Samtani
KA, Darvesh AS and Bishayee A: Pomegranate bioactive constituents
suppress cell proliferation and induce apoptosis in an experimental
model of hepatocellular carcinoma: Role of Wnt/β-catenin signaling
pathway. Evid Based Complement Alternat Med. 2013:3718132013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Manu KA, Shanmugam MK, Ong TH, Subramaniam
A, Siveen KS, Perumal E, Samy RP, Bist P, Lim LH, Kumar AP, et al:
Emodin suppresses migration and invasion through the modulation of
CXCR4 expression in an orthotopic model of human hepatocellular
carcinoma. PLoS One. 8:e570152013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Weng L, Smits P, Wauters J and Merregaert
J: Molecular cloning and characterization of human chondrolectin, a
novel type I transmembrane protein homologous to C-type lectins.
Genomics. 80:62–70. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Weng L, Hubner R, Claessens A, Smits P,
Wauters J, Tylzanowski P, Van Marck E and Merregaert J: Isolation
and characterization of chondrolectin (Chodl), a novel C-type
lectin predominantly expressed in muscle cells. Gene. 308:21–29.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Weng L, Van Bockstaele DR, Wauters J, Van
Marck E, Plum J, Berneman ZN and Merregaert J: A novel alternative
spliced chondrolectin isoform lacking the transmembrane domain is
expressed during T cell maturation. J Biol Chem. 278:19164–19170.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sleigh JN, Barreiro-Iglesias A, Oliver PL,
Biba A, Becker T, Davies KE, Becker CG and Talbot K: Chondrolectin
affects cell survival and neuronal outgrowth in in vitro and in
vivo models of spinal muscular atrophy. Hum Mol Genet. 23:855–869.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhong Z, Ohnmacht J, Reimer MM, Bach I,
Becker T and Becker CG: Chondrolectin mediates growth cone
interactions of motor axons with an intermediate target. J
Neurosci. 32:4426–4439. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Claessens A, Van de Vijver K, Van
Bockstaele DR, Wauters J, Berneman ZN, Van Marck E and Merregaert
J: Expression and localization of CHODLDeltaE/CHODLfDeltaE, the
soluble isoform of chondrolectin. Cell Biol Int. 31:1323–1330.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Masuda K, Takano A, Oshita H, Akiyama H,
Tsuchiya E, Kohno N, Nakamura Y and Daigo Y: Chondrolectin is a
novel diagnostic biomarker and a therapeutic target for lung
cancer. Clin Cancer Res. 17:7712–7722. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dang H, Steinway SN, Ding W and Rountree
CB: Induction of tumor initiation is dependent on CD44s in c-Met+
hepatocellular carcinoma. Bmc Cancer. 15:1612015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Deng L, Li G, Xi L, Yin A, Gao Y, You W,
Wang X and Sun B: Hepatitis B virus inhibition in mice by
lentiviral vector mediated short hairpin RNA. BMC Gastroenterol.
9:732009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Marra M, Sordelli IM, Lombardi A, Lamberti
M, Tarantino L, Giudice A, Stiuso P, Abbruzzese A, Sperlongano R,
Accardo M, et al: Molecular targets and oxidative stress biomarkers
in hepatocellular carcinoma: An overview. J Transl Med. 9:1712011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Altimari A, Fiorentino M, Gabusi E,
Gruppioni E, Corti B, D'Errico A and Grigioni WF: Investigation of
ErbB1 and ErbB2 expression for therapeutic targeting in primary
liver tumours. Dig Liver Dis. 35:332–338. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Forner A, Hessheimer AJ, Real M Isabel and
Bruix J: Treatment of hepatocellular carcinoma. Crit Rev Oncol
Hematol. 60:89–98. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fan ST, Lo CM, Liu CL, Lam CM, Yuen WK,
Yeung C and Wong J: Hepatectomy for hepatocellular carcinoma:
Toward zero hospital deaths. Ann Surg. 229:322–330. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chang LJ, Urlacher V, Iwakuma T, Cui Y and
Zucali J: Efficacy and safety analyses of a recombinant human
immunodeficiency virus type 1 derived vector system. Gene Ther.
6:715–728. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu Y, Butterfield LH, Fu X, Song Z, Zhang
X, Lu C, Ding G and Wu M: Lentivirally engineered dendritic cells
activate AFP-specific T cells which inhibit hepatocellular
carcinoma growth in vitro and in vivo. Int J Oncol. 39:245–253.
2011.PubMed/NCBI
|
|
23
|
Wang Q, Liu QY, Liu ZS, Qian Q, Sun Q and
Pan DY: Lentivirus mediated shRNA interference targeting MAT2B
induces growth-inhibition and apoptosis in hepatocelluar carcinoma.
World J Gastroenterol. 14:4633–4642. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kafri T, Blomer U, Peterson DA, Gage FH
and Verma IM: Sustained expression of genes delivered directly into
liver and muscle by lentiviral vectors. Nat Genet. 17:314–317.
1997. View Article : Google Scholar : PubMed/NCBI
|
